Detection of human parvovirus B19 in a patient with hepatitis

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 9, 2001, Pages 1131-1138

  Pinho, J R R ^a,b   Alves, V A F ^a,c   Vieira, A F ^c   Moralez, M O S ^c   Fonseca, L E P ^c   Guz, B ^d   Wakamatsu, A ^a   Cancado E L R ^c   Carrilho, F J ^c   Da Silva, L C ^c   Bernardini, A P ^b   Durigon, E L ^c  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b Jardim Paulista   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

Author keywords

Autoimmune hepatitis; Hepatitis non A E; Immunohistochemistry; Parvovirus B19; Polymerase chain reaction

Indexed keywords

NON-A, NON-B HEPATITIS VIRUS; PARVOVIRUS;

IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS DNA;

ACUTE DISEASE; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CASE REPORT; CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; MALE; MIDDLE AGED; PARVOVIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS HEPATITIS;

ACUTE DISEASE; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHRONIC DISEASE; DNA, VIRAL; ELECTROPHORESIS, AGAR GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOGLOBULIN M; LIVER; MALE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION;

EID: 0035458449     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000900005     Document Type: Article

References (37)

1. Erdman DD & Durigon EL (1995). Human parvovirus B19. Diagnostic procedures. In: Lennette EH, Lennette DA & Lennette ET (Editors), Diagnostic Procedures of Viral, Rickettsial and Chlamydial Infections. 7th edn. American Public Health Association, Inc., Washington, DC, 495-503.
2. Torok TJ (1992). Parvovirus B19 and human disease. Advances in Internal Medicine, 37: 431-455.
3. Tsuda H (1993). Liver dysfunction caused by parvovirus B19. American Journal of Gastroenterology, 88: 1463 (Letter).
4. Yoto Y, Kudoh T, Asanuma H, Numazaki K, Tsutsumi Y, Nakata S & Chiba S (1994). Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet, 344: 624-625.
5. Yoto Y, Kudoh T, Haseyama K, Suzuki N & Chioa S (1996). Human parvovirus B19 infection associated with acute hepatitis. Lancet, 347: 868-869.
6. Langnas AN, Markin RS, Cattral MS & Naides SJ (1995). Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology, 22: 1661-1665.
7. Naides SJ, Karetnyi YV, Cooling LL, Mark RS & Langnas NA (1996). Human parvovirus B19 infection and hepatitis. Lancet, 347: 1563-1564.
8. Hillingso JG, Jenser IP & Tom-Petersen L (1998). Parvovirus B19 and acute hepatitis in adults. Lancet, 351: 955-956.
9. Longo G, Luppi M, Bertesi M, Ferrara L, Torelli G & Emilia G (1998). Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection. Clinical Infectious Diseases, 26: 994-995.
10. Pardi DS, Romero Y, Mertz LE & Douglas DD (1998). Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. American Journal of Gastroenterology, 93: 468-470.
11. Sokal EM, Melchior M, Cornu C, Vandenbroucke AT, Buts JP, Cohen BJ & Burtonboy G (1998). Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet, 352: 1739-1741.
12. Bernuau J, Durand F & Valla D (1999). Parvovirus B19 infection and fulminant hepatitis. Lancet, 353: 754-755.
13. Yamamoto T, Ise K, Nakashima K, Hayashi J, Nunoue T & Kashiwagi S (1996). Parvovirus B19 as a trigger for spontaneous bacterial peritonitis in a patient with cirrhotic ascites. American Journal of Gastroenterology, 91: 1857-1859.
14. Ndimbie OK, Frezza E, Jordan JA, Koch W & van Thiel DH (1996). Parvovirus B19 in anemic liver transplant recipients. Clinical Diagnosis and Laboratory Immunology, 3: 756-760
15. Garsor JA, Ring C, Tuke P & Tedder RS (1990). Enhanced detection by PCR of hepatitis C virus RNA. Lancet, 337: 878-879.
16. Garson JA, Ring CJ & Tuke PW (1991). Improvement of HCV genome detection with "short" PCR products. Lancet, 338: 1466-1467.
17. Chomczynski P & Sacchi N (1987). Single-step method of RNA isolation by acid guanicinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162: 156-159.
18. Erdman DD, Usher JM, Tsou C, Caul EO, Gary GW, Kajigaya S, Young NS & Anderson LJ (1991). Human parvovirus B19 specific IgG, IgA and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. Journal of Medical Virology, 35: 110-115.
19. Kajigaya S, Fujii H, Field A, Arderson S, Rosenfeld S, Anderson LJ, Shimada T & Young NS (1991). Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proceedings of the National Academy of Sciences, USA, 88: 4646-4650.
20. Durigon EL, Erdman DD, Gary GW, Pallansch MA, Torok TT & Anderson LJ (1993). Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. Journal of Virological Methods, 44: 155-165.
21. Abuaf N, Johanet C & Homberg J-C (1991). Autoantibody pattern in primary biliary cirrhosis. In: Krawitt EL & Wiesner RH (Editors), Autoimmune Liver Diseases. Raven Press, New York, 93-109.
22. Cançado ELR, Vilas-Boas LS, Abrantes-Lemos CP, Novo NF, Porta G, Da Silva LC & Laudanna AA (1996). Heat serum inactivation as a mandatory procedure for anti-actin antibody detection in cell culture. Hepatology, 16: 1098-1104.
23. Berg PA & Klein R (1991). Autoantibodies in autoimmune chronic active hepatitis. In: Krawitt EL & Wiesner RH (Editors), Autoimmune Liver Diseases. Raven Press, New York, 122-141.
24. Wood GS & Warnke R (1981). Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. Journal of Histochemistry and Cytochemistry, 29: 1196-1201.
25. McOmish F, Yap PL, Jordan A, Hart N & Cohen BJ (1993). Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. Journal of Clinical Microbiology, 31: 323-328.
26. Brown KE, Buckley MM, Cohen BJ & Samuel D (1989). An amplified ELISA for the detection of parvovirus B19 IgM using monoclonal antibocy to FITC. Journal of Virological Methods, 26: 189-198.
27. Cossart YE, Field AM, Cant B & Widdows D (1975). Parvovirus-like particles in human sera. Lancet, 1: 72-73.
28. Sasaki T, Murai C, Muryoi T, Takahashi Y, Munakata Y, Sugamura K & Abe K (1995). Persisten; infection of human parvovirus B19 in a normal subject. Lancet, 346: 851 (Letter).
29. Brown KE, Anderson SM & Young NS (1993). Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science, 262: 114-117.
30. Muir K, Todd WT, Watson WH & Fitzsimons E (1992). Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia. Lancet, 339: 1139-1140.
31. Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, Kai T, Suda M & Ueda K (1993). Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. American Journal of Pediatric Hematology and Oncology, 15: 291-298.
32. Pattison JR (1987). B19 virus - a pathogenic human parvovirus. Blood Reviews, 1: 58-64.
33. Kerr JR, Coyle PV, DeLeys RJ & Patterson CC (1996). Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection. Journal of Medical Virology, 48: 68-75.
34. Assy N, Rosenthal E, Hazani A, Etzioni A & Baruch Y (1997). Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation. Journal of Hepatology, 27: 934-936.
35. Kerr JR & Boyd N (1996). Autoantibodies following parvovirus B19 infection. Journal of Infection, 32: 41-47.
36. Hansen KE, Arnason J & Bridges AJ (1998). Autoantibodies and common viral diseases. Seminars in Arthritis and Rheumatism, 27: 263-271.
37. Johnson PJ & McFarlane IG (1993). Meeting Report: International Autoimmune Hepatitis Group. Hepatology, 18: 998-1005.